Skip to main content
OpenTrials

Clinical trial condition

Myelodysplastic-Myeloproliferative Diseases

Explore clinical trials studying Myelodysplastic-Myeloproliferative Diseases. Study availability and eligibility vary by location and protocol.

154 public trials 19 recruiting studies
Refine in advanced search Browse all conditions

Myelodysplastic-Myeloproliferative Diseases trial results

Completed

VNP40101M in Treating Patients With Acute Myelogenous Leukemia or High-Risk Myelodysplasia

NCT00083187

Conditions
Bone Marrow Diseases, Chronic Disease, Congenital Abnormalities, +17 more
Locations
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
  • Duke Comprehensive Cancer Center Durham, North Carolina, United States
  • M.D. Anderson Cancer Center at University of Texas Houston, Texas, United States
  • Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes Marseille, France
View Trial Details
Completed

Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome

NCT00003593

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +17 more
Locations
  • University of Alabama at Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States
  • University of South Alabama Cancer Research Institute Mobile, Alabama, United States
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Arizona Cancer Center at University of Arizona Health Sciences Center Tucson, Arizona, United States
View all 237 locations
View Trial Details
Completed

Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy

NCT00066599

Conditions
Agranulocytosis, Blast Crisis, Blood Protein Disorders, +89 more
Locations
  • Children's Hospital of Orange County Orange, California, United States
  • Children's Hospital and Health Center, San Diego San Diego, California, United States
  • Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States
  • Duke Comprehensive Cancer Center Durham, North Carolina, United States
View Trial Details
Completed

Bevacizumab in Treating Patients With Myelodysplastic Syndrome

NCT00022048

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +17 more
Locations
  • Arizona Cancer Center at University of Arizona Health Sciences Center Tucson, Arizona, United States
  • Stanford Cancer Center at Stanford University Medical Center Stanford, California, United States
  • University of Texas - MD Anderson Cancer Center Houston, Texas, United States
View Trial Details

Related conditions